Ovid Therapeutics Inc. to Post Q3 2023 Earnings of Per Share, William Blair Forecasts
| OVID Stock | USD 1.14 0.03 2.70% |
About 55% of Ovid Therapeutics' shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Ovid Therapeutics suggests that some traders are interested. The current market sentiment, together with Ovid Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Ovid Therapeutics stock news signals to limit their universe of possible portfolio assets.
Ovid |
Ovid Therapeutics Inc. Analysts at William Blair lifted their Q3 2023 earnings per share estimates for Ovid Therapeutics in a research note issued on Tuesday, October 3rd. William Blair analyst T. Lugo now expects that the company will post earnings per share of for the quarter, up from their
Read at thelincolnianonline.com
 |
Ovid Therapeutics Fundamental Analysis
We analyze Ovid Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ovid Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ovid Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Ovid Therapeutics is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Ovid Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ovid Therapeutics stock to make a market-neutral strategy. Peer analysis of Ovid Therapeutics could also be used in its relative valuation, which is a method of valuing Ovid Therapeutics by comparing valuation metrics with similar companies.
Peers
Ovid Therapeutics Related Equities
| CTMX | CytomX Therapeutics | 3.92 | ||||
| CNTB | Connect Biopharma | 2.91 | ||||
| ASMB | Assembly Biosciences | 1.25 | ||||
| ACHL | Achilles Therapeutics | 0.93 | ||||
| SPRO | Spero Therapeutics | 0.88 | ||||
| NUVB | Nuvation Bio | 0.35 | ||||
| NXTC | NextCure | 2.50 | ||||
| TIL | Instil Bio | 9.39 |
Complementary Tools for Ovid Stock analysis
When running Ovid Therapeutics' price analysis, check to measure Ovid Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ovid Therapeutics is operating at the current time. Most of Ovid Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ovid Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ovid Therapeutics' price. Additionally, you may evaluate how the addition of Ovid Therapeutics to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |